Stay updated on Pembrolizumab with Targeted Therapy Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab with Targeted Therapy Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab with Targeted Therapy Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    The NIH website-transition notice, including its update link and terminology announcement, is no longer displayed above the 403 error page.
    Difference
    1%
    Check dated 2026-11-10T15:29:57.000Z thumbnail image
  2. Check
    13 days ago
    Change Detected
    Summary
    The footer revision label changed from v3.7.2 to v3.8.0, while the page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-11-03T16:28:09.000Z thumbnail image
  3. Check
    27 days ago
    Change Detected
    Summary
    An NIH-wide transition notice banner appears above the 403 error page, and the site revision changes from v3.7.1 to v3.7.2.
    Difference
    1%
    Check dated 2026-10-20T16:57:08.000Z thumbnail image
  4. Check
    34 days ago
    Change Detected
    Summary
    The footer revision identifier changed from v3.7.0 to v3.7.1. The page continues to show a 403 error rather than study details.
    Difference
    0.2%
    Check dated 2026-10-13T17:13:15.000Z thumbnail image
  5. Check
    55 days ago
    Change Detected
    Summary
    403 Forbidden is now displayed, replacing the full study record with a minimal header and navigation. The section containing study documents and links appears to have been removed, indicating the content is no longer accessible on this page.
    Difference
    22%
    Check dated 2026-09-22T21:51:09.000Z thumbnail image
  6. Check
    62 days ago
    Change Detected
    Summary
    Revision: v3.7.0 is displayed on the page, signaling a platform update. This change reflects an update to the site's version rather than any modification to the study data or displayed details.
    Difference
    0.0%
    Check dated 2026-09-15T21:45:42.000Z thumbnail image

Stay in the know with updates to Pembrolizumab with Targeted Therapy Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab with Targeted Therapy Clinical Trial page.